ESC 23: Hot Line & Late-breaking Science Video Collection
Published: 04 August 2023
-
Views:
4102
-
Likes:
7
-
Views:
4102
-
Likes:
7
-
13m 28sPart 3 | Session 1 Day 1 Highlights: New Guidelines, STEP-HFpEF, COP-AF -
16m 34sPart 3 | Session 2 Day 2 Highlights: BUDAPEST-CRT, FIRE, ECLS-Shock, STOPDAPT-3 -
13m 51sPart 3 | Session 3 Day 3 Highlights: OCT Trials, MULTISTARS-AMI, ATTRibute-CM -
8m 3sPart 3 | Session 4 Day 4 Highlights: OPT-BIRISK & NITRATE-CIN
-
6m 46sPart 4 | Session 1 New Guidelines For the Management of Acute Coronary Syndromes -
3m 42sPart 4 | Session 2 NOAH-AFNET 6: Oral Anticoagulation in Pts With AHRE -
3m 42sPart 4 | Session 3 LODESTAR: Rosuvastatin Vs Atorvastatin Treatment For CAD Patients -
6m 14sPart 4 | Session 4 Economic Burden of Cardiovascular Disease in the EU -
3m 22s -
4m 1s -
3m 59sPart 4 | Session 7 HEART-FID: Ferric Carboxymaltose in HF with Iron Deficiency -
4m 49sPart 4 | Session 8 SurHyb Trial: Hybrid Ablation in Persistent Atrial Fibrillation -
4m 41s -
4m 12sPart 4 | Session 10 ILUMIEN IV: OCT Vs Angiography -
5m 20sPart 4 | Session 11 ReDS-SAFE HF: ReDS-Guided Strategy in Heart Failure -
5m 23sPart 4 | Session 12 MULTISTARS AMI: Immediate Vs Staged PCI in STEMI and MVD -
6m 3sPart 4 | Session 13 OCT Vs IVUS Vs Angiography Guidance -
4m 5sPart 4 | Session 14 OCTOBER: OCT-Guided or Angiography-Guided PCI in Complex Bifurcation Lesions -
2m 55sPart 4 | Session 15 DANPACE II: Reducing Atrial Pacing in Sinus Node Disease -
6m 43sPart 4 | Session 16 COP-AF: Colchicine for Perioperative AF -
4m 33sPart 4 | Session 17 CASTLE-HTx: Catheter Ablation for AF in Pts with Heart Failure -
4m 53sPart 4 | Session 18 OCTIVUS: OCT Vs IVUS-Guided Percutaneous Coronary Intervention -
4m 56sPart 4 | Session 19 PUSH-AHF: Natriuresis-Guided Therapy in Acute Heart Failure -
4m 16s -
4m 8sPart 4 | Session 21 ONCO DVT: Optimal Duration of DOAC Therapy for IDDVT Patients with Cancer -
4m 39sPart 4 | Session 22 ATTRibute-CM Trial -
5m 21sPart 4 | Session 23 RIGHT: Post-PPCI Anticoagulation in STEMI Patients -
6m 1sPart 4 | Session 24 ARAMIS: Anakinra versus Placebo in Acute Myocarditis -
4m 9s
-
6m 42sPart 5 | Session 1 Takeaways from ESC 2023 with Dr Cvijic & Dr Grapsa -
9m 47sPart 5 | Session 2 Takeaways from ESC 2023 with Dr Al-Lamee, Dr Colleran & Dr Paradies
-
3m 33sPart 6 | Session 1 Leadership in Guidelines and Cardiovascular Education with Dr Robert Byrne -
59sPart 6 | Session 2 Patient Care and Treatment Strategies with Dr Myeong-Ki Hong -
2m 2s -
1m 27sPart 6 | Session 4 Intersection of Politics and Medicine with Dr Luengo-Fernandez -
1m 24sPart 6 | Session 5 Choosing Cardiology and Advice to Researchers with Dr Robert Mentz -
1m 10sPart 6 | Session 6 Leadership in the Context of Clinical Trials with Dr Michelle O'Donoghue -
46sPart 6 | Session 7 Trials to Watch Out For with Dr Masahiro Natsuaki -
49s -
1m 2sPart 6 | Session 9 Emerging Topics in Electrophysiology with Dr Tobias Reichlin -
1m 23sPart 6 | Session 10 Key Trials and Data from ESC 23 with Dr Ziad Ali -
36s -
58sPart 6 | Session 12 Inspiring Teams with Prof Barbara Stahli -
2m 21sPart 6 | Session 13 Advice for Early-Career Researchers from Dr Gregg Stone -
48sPart 6 | Session 14 New Technologies in Electrophysiology with Dr Mads Brix Kronborg -
1m 25sPart 6 | Session 15 Considering Unmet Needs in Patient Care with Dr Duk-Woo Park -
59sPart 6 | Session 16 Improving Clinical Practice with Dr Do-Yoon Kang -
1m 28sPart 6 | Session 17 Contributing to the Guidelines with Dr Jozine Ter Maaten -
2m 41sPart 6 | Session 18 Emerging Trends in Amyloidosis with Prof Julian Gillmore -
30sPart 6 | Session 19 Working With Role Models with Dr Yan Yan -
1m 17sPart 6 | Session 20 The Importance of Mentorship with Dr Giles Montalescot -
1m 24sPart 6 | Session 21 Personalised Medicine & Team Approach With Dr Christian Sohns -
1m 51sPart 6 | Session 22 Advancement of EP & Adapting New Approaches With Dr Philipp Sommer -
2m 14s
-
47m 55sPart 1 | Session 1 ESC 23 Late-breaking Science Wrap Up Nicolas M Van Mieghem, Joost Daemen
-
28m 31sPart 1 | Session 2 ESC 23 Late-breaking Science Preview Joost Daemen, Nicolas M Van Mieghem
-
13m 31sPart 2 | Session 1 The ECLS-Shock Trial Harriette Van Spall, Holger Thiele
-
13m 24sPart 2 | Session 2 The STEP HFpEF Trial Harriette Van Spall, Mikhail Kosiborod
-
9m 37sPart 2 | Session 3 The RECORD MI Registry Harriette Van Spall, Javed Butler
Overview
What's hot at the European Society of Cardiology (ESC) Congress 2023?
Browse our curated coverage of the latest updates in cardiology from Amsterdam.
- Watch our View From the Thoraxcenter series for a concise line up of the most awaited trials from Prof Nicolas Van Mieghem and Dr Joost Daemen.
- For a deeper dive into key clinical trial data and its applicability, host, Dr Harriette Van Spall meets with Principal Investigators in her Late-Breaker Discussion series.
- View a condensed summary of the crucial takeaways from each day in our Wrap-Up series with Dr Mirvat Alasnag.
- Our short, accessible Expert Interviews with select faculty focus on data, patient care and the future of their field.
- We will feature personal perspective in Behind the Heart series focusing on career pathways, personal motivations and perspectives on the field.
More from this programme
Part 1
View From the Thoraxcenter
Part 2
Late-Breaker Discussions with Dr Harriette Van Spall
Part 3
Daily Wrap-Ups with Dr Alasnag & Dr Al-Shaibi
Part 4
Expert Interviews
Part 5
Women as One & Radcliffe Cardiology Presents
Part 6
Behind the Heart
About the episode
Join the Late-breaker host, Dr Harriette Van Spall (McMaster University, CA), and Dr Milton Packer (Baylor University Medical Center, US) for a thought-provoking discussion on the present and future of heart failure care at ESC Congress 2023.
In this unique exchange, Dr Packer shares his thoughts on heart failure guidelines and the '2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure,' while asking critical questions pertaining to categorisation and more.
Dr Van Spall asks Dr Packer about the hot line trial, STEP HFpEF, which examined how semaglutide performed in people dealing with both heart failure and obesity (NCT04788511).They put the trial in context by delving deeper into the question of BMI as a metric.
Next, Dr Packer highlights the question of bias in Western medicine and the unexpected results of the QUEST trial, the first randomised, double-blind controlled trial of traditional Chinese medicine for the treatment of chronic heart failure. Dr Packer poses the question: Is Western medicine based on stories or evidence-based medicine?
We learn Dr Packer’s one wish for the future of healthcare and his vision for heart failure care. Could we achieve better care with a non-human workforce?
Lastly, Dr Van Spall and Dr Packer focus on the question of trust and how we can rebuild it between patients and healthcare workers.
Faculty Biographies
Milton Packer
Distinguished Scholar in Cardiovascular Science
Personal History
Dr Milton Packer was born to Polish immigrants in 1951 and raised in Philadelphia, US. Prior to studying medicine, he was politically active in the 1960s. In his words: “The focus of my upbringing was education, but the major guiding principle in my childhood years (and throughout my entire life) was an uncompromising sense of justice. I was always imbued with the need to strive for and defend the truth.” He began his career in cardiology during a pivotal time for the field, just as interventional cardiology and
Harriette Van Spall
Associate Professor of Medicine, Director of E-Health and Virtual Care
Dr Harriette Van Spall is an Associate Professor of Medicine and cardiologist and serves as Director of E-Health at McMaster University, Canada. She completed her medical and postgraduate clinical training at the University of Toronto and earned a Master of Public Health degree at Harvard University, US. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.
She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals. She is an invited speaker, media correspondent, and editorial board member active in peer review at several high-impact medications journals and grant funding agencies, including Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.
Dr Van Spall is an Editorial Board…
Comments